FELICE, CARLA
FELICE, CARLA
Dipartimento di Medicina - DIMED
Intima-media thickness in inflammatory bowel disease patients: A still open question [9]
2008 Papa, A.; Bonizzi, M.; Andrisani, G.; Felice, C.; Mocci, G.; Gasbarrini, A.
Vascular involvement in inflammatory bowel disease: Pathogenesis and clinical aspects
2008 Papa, A.; Scaldaferri, F.; Danese, S.; Guglielmo, S.; Roberto, I.; Bonizzi, M.; Mocci, G.; Felice, C.; Ricci, C.; Andrisani, G.; Fedeli, G.; Gasbarrini, G.; Gasbarrini, A.
Biological therapies for inflammatory bowel disease: Controversies and future options
2009 Papa, A.; Mocci, G.; Bonizzi, M.; Felice, C.; Andrisani, G.; Papa, G.; Gasbarrini, A.
Use of infliximab in particular clinical settings: Management based on current evidence
2009 Papa, A.; Mocci, G.; Bonizzi, M.; Felice, C.; Andrisani, G.; De Vitis, I.; Guidi, L.; Gasbarrini, A.
New therapeutic approach in inflammatory bowel disease
2009 Papa, A; Mocci, G; Scaldaferri, F; Bonizzi, M; Felice, C; Andrisani, G; Gasbarrini, A
New biological agents for the treatment of the "high risk" IBD patients
2010 Guidi, L; Marzo, M; Felice, C; Mocci, G; Sparano, L; Pugliese, D; De Vitis, I; Papa, A; Armuzzi, A
A case of hereditary hemorrhagic telangiectasia associated with crohn's disease successfully treated with infliximab
2010 Papa, A.; Felice, C.; Marzo, M.; Guidi, L.
Infliximab: A review of its use in the treatment of inflammatory Bowel disease
2011 Marzo, M.; Felice, C.; Rapaccini, G. L.; Guidi, L.; Armuzzi, A.
Total Abdominal Colectomy for Refractory Ulcerative Colitis. Surgical Treatment in Evolution
2011 Fichera, A.; Zoccali, M.; Felice, C.; Rubin, D. T.
Ileal Crohn's disease: CEUS determination of activity
2012 De Franco, A.; Marzo, M.; Felice, C.; Pugliese, D.; Di Veronica, A.; Bonomo, L.; Armuzzi, A.; Guidi, L.
Non-biological therapy in inflammatory bowel disease-old and new evidence
2012 Felice, C.; Guidi, L.; Armuzzi, A.
AID in aging and autoimmune diseases
2013 Frasca, D.; Andrisani, G.; Diaz, A.; Felice, C.; Guidi, L.; Blomberg, B. B.
Achievement of sustained deep remission with Adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis
2013 Andrisani, G.; Gremese, E.; Guidi, L.; Papa, A.; Marzo, M.; Felice, C.; Pugliese, D.; Armuzzi, A.
Inducing remission of ulcerative colitis: Are clinicians better equipped than ever?
2013 Armuzzi, A.; Felice, C.
Natalizumab in Crohn's disease: Past and future areas of applicability
2013 Armuzzi, A.; Felice, C.
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients
2013 Andrisani, G; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Pugliese, D; De Vitis, I; Rapaccini, Gl; Guidi, L
FOXP3+ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNF α agents
2013 Guidi, L.; Felice, C.; Procoli, A.; Bonanno, G.; Martinelli, E.; Marzo, M.; Mocci, G.; Pugliese, D.; Andrisani, G.; Danese, S.; De Vitis, I.; Papa, A.; Armuzzi, A.; Rutella, S.
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants
2013 Andrisani, G.; Frasca, D.; Romero, M.; Armuzzi, A.; Felice, C.; Marzo, M.; Pugliese, D.; Papa, A.; Mocci, G.; De Vitis, I.; Rapaccini, G. L.; Blomberg, B. B.; Guidi, L.
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study
2013 Armuzzi, A.; Felice, C.; Papa, A.; Marzo, M.; Pugliese, D.; Andrisani, G.; Federico, F.; De Vitis, I.; Rapaccini, G. L.; Guidi, L.
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents
2013 Papa, A.; Felice, C.; Marzo, M.; Andrisani, G.; Armuzzi, A.; Covino, M.; Mocci, G.; Pugliese, D.; De Vitis, I.; Gasbarrini, A.; Rapaccini, G. L.; Guidi, L.